Leonardo L. Seidl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leonardo L. Seidl has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Cecilia Ortíz
Redox Biology of Trypanosomes, Institut Pasteur de Montevideo, Mataojo 2020, Montevideo 11400, Uruguay
2 shared publications - Conrad Kunick
Institut für Medizinische und Pharmazeutische Chemie, Technische Universität Braunschweig, Braunschweig, Germany
2 shared publications - Marcelo Alberto Comini
Group Redox Biology of Trypanosomes, Institut Pasteur de Montevideo, Montevideo, Uruguay.
2 shared publications - Marco J. Müller
Institute of Medicinal and Pharmaceutical Chemistry, TU Braunschweig, Braunschweig, Germany
2 shared publications Diego Benítez
Laboratory Redox Biology of Trypanosomes, Institut Pasteur de Montevideo, Montevideo, Uruguay
1 shared publication- Diego Benítez
Laboratory Redox Biology of Trypanosomes, Institut Pasteur de Montevideo, Montevideo, Uruguay
1 shared publication
Latest Publications
- Open Access
- 11 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Comprehensive synthesis of K48/K63 ubiquitin pentamers by graph-empowered automation
Linear, branched, and heterotypic ubiquitin (Ub) chains regulate essential cellular processes, yet their structural and functional analysis remains limited by the difficulty of preparing defined, homogeneous samples by chemical synthesis or biochemical assembly. We established a fully automated platform for the comprehensive synthesis of all 56 K48/K63-linked Ub tetramers and pentamers. This is achieved by iterative cycles of K48 or K63-specific chemoenzymatic conjugations of chemically synthesized Ub monomers bearing a new, fast-cleaving lysine protecting group compatible with folded proteins. A graph-based digital encoding of the Ub chain topologies enabled systematic enumeration and filtering of reaction pathways, guiding the selection of viable synthetic routes. This computational system generates reagent maps and executable code to direct iterative cycles of deprotection and conjugation on a standard, laboratory liquid handling robot. All 14 Ub tetramers and 42 Ub pentamers were obtained with high fidelity, as validated by SDS-PAGE and mass spectrometry. This work establishes a general framework for automated protein conjugate synthesis and provides on-demand access to the complete space of K48/K63 branched ubiquitin chains for biological and structural studies.
- 11 September 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessComprehensive synthesis of K48/K63 ubiquitin pentamers by graph-empowered automation
Linear, branched, and heterotypic ubiquitin (Ub) chains regulate essential cellular processes, yet their structural and functional analysis remains limited by the difficulty of preparing defined, homogeneous samples by chemical synthesis or biochemical assembly. We established a fully automated platform for the comprehensive synthesis of all 56 K48/K63-linked Ub tetramers and pentamers. This is achieved by iterative cycles of K48 or K63-specific chemoenzymatic conjugations of chemically synthesized Ub monomers bearing a new, fast-cleaving lysine protecting group compatible with folded proteins. A graph-based digital encoding of the Ub chain topologies enabled systematic enumeration and filtering of reaction pathways, guiding the selection of viable synthetic routes. This computational system generates reagent maps and executable code to direct iterative cycles of deprotection and conjugation on a standard, laboratory liquid handling robot. All 14 Ub tetramers and 42 Ub pentamers were obtained with high fidelity, as validated by SDS-PAGE and mass spectrometry. This work establishes a general framework for automated protein conjugate synthesis and provides on-demand access to the complete space of K48/K63 branched ubiquitin chains for biological and structural studies.
- 25 June 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 661, 124390
Antisense oligonucleotides and their technical suitability to nebulization
- 25 June 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 661, 124390
Antisense oligonucleotides and their technical suitability to nebulization
- Open Access
- 30 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0292946
The indole motif is essential for the antitrypanosomal activity of N5-substituted paullones
Severe infections with potentially fatal outcomes are caused by parasites from the genera Trypanosoma and Leishmania (class Kinetoplastea). The diseases affect people of remote areas in the tropics and subtropics with limited access to adequate health care. Besides insufficient diagnostics, treatment options are limited, with tenuous developments in recent years. Therefore, new antitrypanosomal antiinfectives are required to fight these maladies. In the presented approach, new compounds were developed and tested on the target trypanothione synthetase (TryS). This enzyme is crucial to the kinetoplastids’ unique trypanothione-based thiol redox metabolism and thus for pathogen survival. Preceding studies have shown that N5-substituted paullones display antitrypanosomal activity as well as TryS inhibition. Herein, this compound class was further examined regarding the structure-activity relationships (SAR). Diverse benzazepinone derivatives were designed and tested in cell-based assays on bloodstream Trypanosoma brucei brucei (T. b. brucei) and intracellular amastigotes of Leishmania infantum (L. infantum) as well as in enzyme-based assays on L. infantum TryS (LiTryS) and T. b. brucei TryS (TbTryS). While an exchange of just the substituent in the 9-position of paullones led to potent inhibitors on LiTryS and T. b. brucei parasites, new compounds lacking the indole moiety showed a total loss of activity in both assays. Conclusively, the indole as part of the paullone structure is pivotal for keeping the TryS inhibitory and antitrypanosomal activity of this substance class.
- 30 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0292946
Open AccessThe indole motif is essential for the antitrypanosomal activity of N5-substituted paullones
Severe infections with potentially fatal outcomes are caused by parasites from the genera Trypanosoma and Leishmania (class Kinetoplastea). The diseases affect people of remote areas in the tropics and subtropics with limited access to adequate health care. Besides insufficient diagnostics, treatment options are limited, with tenuous developments in recent years. Therefore, new antitrypanosomal antiinfectives are required to fight these maladies. In the presented approach, new compounds were developed and tested on the target trypanothione synthetase (TryS). This enzyme is crucial to the kinetoplastids’ unique trypanothione-based thiol redox metabolism and thus for pathogen survival. Preceding studies have shown that N5-substituted paullones display antitrypanosomal activity as well as TryS inhibition. Herein, this compound class was further examined regarding the structure-activity relationships (SAR). Diverse benzazepinone derivatives were designed and tested in cell-based assays on bloodstream Trypanosoma brucei brucei (T. b. brucei) and intracellular amastigotes of Leishmania infantum (L. infantum) as well as in enzyme-based assays on L. infantum TryS (LiTryS) and T. b. brucei TryS (TbTryS). While an exchange of just the substituent in the 9-position of paullones led to potent inhibitors on LiTryS and T. b. brucei parasites, new compounds lacking the indole moiety showed a total loss of activity in both assays. Conclusively, the indole as part of the paullone structure is pivotal for keeping the TryS inhibitory and antitrypanosomal activity of this substance class.
- Open Access
- 28 March 2023
- Published by Wiley in ChemMedChem
- Vol. 18 (10) , e202300036
Discovery of Antitrypanosomal Indolylacetamides by a Deconstruction–Optimization Strategy Applied to Paullones
The parasitic kinetoplastid diseases Leishmaniasis, Chagas disease and Human African Trypanosomiasis constitute serious threats for populations throughout the (sub‐)tropics. Most available drugs to treat these diseases possess inadequate properties and candidates to fill the drug pipeline are urgently needed. Paullone‐N5‐acetamides inhibit trypanothione synthetase (TryS), an essential kinetoplastid enzyme, and exhibit antiparasitic activity in the low micromolar range, but lack the desired selectivity against mammalian cells (selectivity index (SI):25).
- 28 March 2023
- Published by Wiley in ChemMedChem
- Vol. 18 (10) , e202300036
Open AccessDiscovery of Antitrypanosomal Indolylacetamides by a Deconstruction–Optimization Strategy Applied to Paullones
The parasitic kinetoplastid diseases Leishmaniasis, Chagas disease and Human African Trypanosomiasis constitute serious threats for populations throughout the (sub‐)tropics. Most available drugs to treat these diseases possess inadequate properties and candidates to fill the drug pipeline are urgently needed. Paullone‐N5‐acetamides inhibit trypanothione synthetase (TryS), an essential kinetoplastid enzyme, and exhibit antiparasitic activity in the low micromolar range, but lack the desired selectivity against mammalian cells (selectivity index (SI):25).